BioSpace News Archive

BioMidwest

Johnson & Johnson Vision Presents Findings from New Myopia Research and Highlights Latest Contact Lens Innovations for Patients with Presbyopia at Academy 2021

Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, announced that new myopia data outcomes will be presented at the upcoming 2021 American Academy of Optometry annual meeting in Boston, November 3-6.

November 2, 2021
·
5 min read
Business

Resolve Biosciences Strengthens Leadership Team with Appointment of Frank Zhong as Chief Technology Officer

Resolve Biosciences , the pioneer in Molecular Cartography™, today announced the appointment of Frank Zhong, PhD, as Chief Technology Officer.

November 2, 2021
·
4 min read
Business

Palleon Pharmaceuticals Appoints David Johnson to Its Board of Directors

Palleon Pharmaceuticals today announced the appointment of David Johnson as an independent director to its Board of Directors.

November 2, 2021
·
2 min read
Biotech Beach

Equillium Announces Interim Safety Data and Reduction in Proteinuria for Lupus Patients Treated with Itolizumab in the EQUALISE Study Presented at the ACR Annual Meeting

Equillium, Inc. today announced that positive interim data from the Type A portion of the EQUALISE study in systemic lupus erythematosus (SLE) patients were presented in a poster session at the American College of Rheumatology (ACR) annual meeting.

November 2, 2021
·
8 min read
Drug Development

Aldeyra Therapeutics Announces Achievement of Primary Endpoint of Ocular Redness in Randomized, Double-Masked, Vehicle-Controlled Phase 2 Clinical Trial in Dry Eye Disease

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced achievement of the primary endpoint of ocular redness in a randomized, double-masked, vehicle-controlled Phase 2 clinical trial in patients with dry eye disease.

November 2, 2021
·
9 min read
Business

Rebus Biosystems Appoints World-leading Researchers to Scientific Advisory Board

Arul Chinnaiyan and Sten Linnarsson to bolster Rebus expertise and scientific direction

November 2, 2021
·
3 min read
Biotech Bay

Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List

Twist Bioscience Corporation announced that it has been included in Inc.’s first annual Best-Led Companies list, an exciting 12-point measure of management excellence across the middle market — a select, data-driven list of the very strongest U.S. firms with revenue of $50 million to $2 billion.

November 2, 2021
·
5 min read
Business

Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the appointment of Brian M. Johnson as its Chief Commercial Officer.

November 2, 2021
·
8 min read
Business

Resonant to Report Third Quarter 2021 Financial Results on Wednesday, November 10th at 3:30 P.M. Central Time

Resonant Inc will release financial results for the third quarter ended September 30th , 2021 after market close on Wednesday, November 10 th , 2021.

November 2, 2021
·
2 min read
Business

Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia

Quoin Pharmaceuticals Ltd. today announced that it has signed an agreement with Queensland University of Technology, Australia (QUT).

November 2, 2021
·
3 min read